4 employees
Boreal develops research tools and diagnostic tests based on the monitoring of tumor mutations from cell-free DNA in plasma.
2007
$18M
from 3 investors over 3 rounds
Boreal Genomics raised $18M on October 4, 2013
Investors: ARCH Venture Partners and Kearny Venture Partners
Boreal Genomics raised $6.5M on October 1, 2010
Investors: In-Q-Tel